Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


14.05.2018

1 Adv Urol
1 Anticancer Drugs
1 Anticancer Res
6 Arch Esp Urol
3 BJU Int
7 Bladder Cancer
1 Br J Nurs
1 Cancer
1 Cancer Res Treat
1 Cent European J Urol
1 Clin Genitourin Cancer
1 Clin Lab
1 Expert Opin Emerg Drugs
1 Expert Rev Anticancer Ther
1 Int J Biol Sci
1 Int J Environ Res Public Health
1 Int J Med Sci
1 Investig Clin Urol
1 J Am Coll Radiol
1 J BUON
1 J Clin Oncol
1 J Occup Health
1 J Urol
2 Jpn J Clin Oncol
1 Kaohsiung J Med Sci
1 Med Sci Monit
7 Methods Mol Biol
2 Mol Clin Oncol
2 Mol Med Rep
5 Oncol Lett
1 Oncol Rep
1 Oncotarget
4 Transl Androl Urol
1 Urol Oncol
1 Urologe A
1 World J Urol
1 Zhonghua Zhong Liu Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Adv Urol

  1. KYRITSI F, Loffredo CA, Zheng YL, Philips G, et al
    Urinary Bladder Cancer in Egypt: Are There Gender Differences in Its Histopathological Presentation?
    Adv Urol. 2018;2018:3453808.
    PubMed     Text format     Abstract available


    Anticancer Drugs

  2. FANG CY, Chen JS, Chang SK, Shen CH, et al
    Reversine induces autophagic cell death through the AMP-activated protein kinase pathway in urothelial carcinoma cells.
    Anticancer Drugs. 2018;29:29-39.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. OWARI T, Miyake M, Nakai Y, Morizawa Y, et al
    A Genitourinary Cancer-specific Scoring System for the Prediction of Survival in Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma.
    Anticancer Res. 2018;38:3097-3103.
    PubMed     Text format     Abstract available


    Arch Esp Urol

  4. CHANTADA-ABAL V, Chantada-Tirado C, Lamas-Diaz L, Carames-Masana F, et al
    [Sequential treatment with Mitomycin C and BCG in non muscle invasive bladder cancer.]
    Arch Esp Urol. 2018;71:453-457.
    PubMed     Text format     Abstract available

  5. SOUSA ESCANDON A
    Something is changing in the diagnosis and treatment of non-muscle invasive bladder cancers (NMIBC).
    Arch Esp Urol. 2018;71:325-327.
    PubMed     Text format    

  6. SANCHEZ GONZALEZ A, Rodriguez Faba O, Mosquera L, Sabiote L, et al
    [BCG and bladder cancer: Past, present and future.]
    Arch Esp Urol. 2018;71:332-341.
    PubMed     Text format     Abstract available

  7. LEON-MATA J, Dominguez JL, Redorta JP, Sousa Gonzalez D, et al
    Analysis of tolerance and security of chemo hyperthermia with Mitomycin C for the treatment of non-muscle invasive bladder cancer.
    Arch Esp Urol. 2018;71:426-437.
    PubMed     Text format     Abstract available

  8. AMINSHARIFI A, Brousell SC, Chang A, Leon J, et al
    Heat-targeted drug delivery: A promising approach for organsparing treatment of bladder cancer.THERMODOX(R).
    Arch Esp Urol. 2018;71:447-452.
    PubMed     Text format     Abstract available

  9. COENEN JJMJH, van Valenberg FJP, Arends TJH, Witjes JA, et al
    [Chemohyperthermia using MMC in non-muscle-invasive bladder cancer: Current status and future perspectives.]
    Arch Esp Urol. 2018;71:400-408.
    PubMed     Text format     Abstract available


    BJU Int

  10. GANDHI N, Krishna S, Booth CM, Breau RH, et al
    Diagnostic accuracy of MRI for tumor staging of bladder cancer: Systematic review and Meta-Analysis.
    BJU Int. 2018 May 4. doi: 10.1111/bju.14366.
    PubMed     Text format     Abstract available

  11. MASON SJ, Catto JW, Downing A, Bottomley SE, et al
    Evaluating Patient Reported Outcome Measures (PROMs) for bladder cancer: a systematic review using the COSMIN checklist.
    BJU Int. 2018 May 3. doi: 10.1111/bju.14368.
    PubMed     Text format     Abstract available

  12. NA R, Wu Y, Jiang G, Yu H, et al
    Germline Mutations in DNA Repair Genes are Associated with Bladder Cancer Risk and Unfavorable Prognosis.
    BJU Int. 2018 May 4. doi: 10.1111/bju.14370.
    PubMed     Text format     Abstract available


    Bladder Cancer

  13. ZUIVERLOON TCM, de Jong FC, Costello JC, Theodorescu D, et al
    Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines.
    Bladder Cancer. 2018;4:169-183.
    PubMed     Text format     Abstract available

  14. KAISER J, Li H, North SA, Leibowitz-Amit R, et al
    The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study.
    Bladder Cancer. 2018;4:185-194.
    PubMed     Text format     Abstract available

  15. ZAREBA P, Duivenvoorden WCM, Pinthus JH
    Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention.
    Bladder Cancer. 2018;4:139-147.
    PubMed     Text format     Abstract available

  16. LEWIS GD, Haque W, Verma V, Butler EB, et al
    The Role of Adjuvant Radiation Therapy in Locally Advanced Bladder Cancer.
    Bladder Cancer. 2018;4:205-213.
    PubMed     Text format     Abstract available

  17. GALSKY MD, Pal SK, Lin SW, Ogale S, et al
    Real-World Effectiveness of Chemotherapy in Elderly Patients With Metastatic Bladder Cancer in the United States.
    Bladder Cancer. 2018;4:227-238.
    PubMed     Text format     Abstract available

  18. MESSING EM
    Psychological Stress and Suicide in Bladder Cancer Patients.
    Bladder Cancer. 2018;4:245-246.
    PubMed     Text format    

  19. DE MATURANA EL, Rava M, Anumudu C, Saez O, et al
    Bladder Cancer Genetic Susceptibility. A Systematic Review.
    Bladder Cancer. 2018;4:215-226.
    PubMed     Text format     Abstract available


    Br J Nurs

  20. ANDERSON B
    Bladder cancer: overview and disease management. Part 1: non-muscle-invasive bladder cancer.
    Br J Nurs. 2018;27:S27-S37.
    PubMed     Text format     Abstract available


    Cancer

  21. SMITH AB, Chisolm S, Deal A, Spangler A, et al
    Patient-centered prioritization of bladder cancer research.
    Cancer. 2018 May 4. doi: 10.1002/cncr.31530.
    PubMed     Text format     Abstract available


    Cancer Res Treat

  22. SHIN DW, Park HS, Lee SH, Jeon SH, et al
    Health-Related Quality of Life, Perceived Social Support, and Depression in Disease-Free Survivors Who Underwent Curative Surgery Only for Prostate, Kidney and Bladder cancer: Comparison among survivors and with the General Population.
    Cancer Res Treat. 2018 May 4. pii: crt.2018.053. doi: 10.4143/crt.2018.
    PubMed     Text format     Abstract available


    Cent European J Urol

  23. AL JOHI RS, Seifeldein GS, Moeen AM, Aboulhagag NA, et al
    Diffusion weighted magnetic resonance imaging in bladder cancer, is it time to replace biopsy?
    Cent European J Urol. 2018;71:31-37.
    PubMed     Text format     Abstract available


    Clin Genitourin Cancer

  24. FLANNERY K, Cao X, He J, Zhong Y, et al
    Survival Rates and Health Care Costs for Patients With Advanced Bladder Cancer Treated and Untreated With Chemotherapy.
    Clin Genitourin Cancer. 2018 Mar 27. pii: S1558-7673(18)30211.
    PubMed     Text format     Abstract available


    Clin Lab

  25. LUAN T, Zou R, Huang L, Li N, et al
    Hsa-miR-3658 Promotes Cell Proliferation, Migration and Invasion by Effecting LASS2 in Bladder Cancer.
    Clin Lab. 2018;64:515-525.
    PubMed     Text format     Abstract available


    Expert Opin Emerg Drugs

  26. CRIJNEN J, de Reijke TM
    Emerging intravesical drugs for the treatment of non muscle-invasive bladder cancer.
    Expert Opin Emerg Drugs. 2018 May 5. doi: 10.1080/14728214.2018.1474201.
    PubMed     Text format     Abstract available


    Expert Rev Anticancer Ther

  27. D'ANDREA D, Hassler MR, Abufaraj M, Soria F, et al
    Progressive tissue biomarker profiling in non-muscle-invasive bladder cancer.
    Expert Rev Anticancer Ther. 2018 May 9:1-9. doi: 10.1080/14737140.2018.1474104.
    PubMed     Text format     Abstract available


    Int J Biol Sci

  28. LIN W, Xie J, Xu N, Huang L, et al
    Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells.
    Int J Biol Sci. 2018;14:418-426.
    PubMed     Text format     Abstract available


    Int J Environ Res Public Health

  29. CHU HA, Crawford-Brown D
    Correction: Chu et al. Inorganic Arsenic in Drinking Water and Bladder Cancer: A Meta-Analysis for Dose-Response Assessment. Int. J. Environ. Res. Public Health 2006, 3(4), 316(-)322.
    Int J Environ Res Public Health. 2018;15.
    PubMed     Text format    


    Int J Med Sci

  30. DONG L, Lin F, Wu W, Liu Y, et al
    Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway.
    Int J Med Sci. 2018;15:645-652.
    PubMed     Text format     Abstract available


    Investig Clin Urol

  31. YOSHIDA T, Singh AK, Bishai WR, McConkey DJ, et al
    Organoid culture of bladder cancer cells.
    Investig Clin Urol. 2018;59:149-151.
    PubMed     Text format    


    J Am Coll Radiol

  32. VAN DER POL CB, Sahni VA, Eberhardt SC, Oto A, et al
    ACR Appropriateness Criteria((R)) Pretreatment Staging of Muscle-Invasive Bladder Cancer.
    J Am Coll Radiol. 2018;15.
    PubMed     Text format     Abstract available


    J BUON

  33. CAO Y, He Y, Chen H, He S, et al
    Phase I study of gemcitabine-cisplatin versus pemetrexed cisplatin for patients with advanced or metastatic bladder cancer.
    J BUON. 2018;23:475-481.
    PubMed     Text format     Abstract available


    J Clin Oncol

  34. IYER G, Balar AV, Milowsky MI, Bochner BH, et al
    Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer.
    J Clin Oncol. 2018 May 9:JCO2017750158. doi: 10.1200/JCO.2017.75.0158.
    PubMed     Text format     Abstract available


    J Occup Health

  35. NAKANO M, Omae K, Takebayashi T, Tanaka S, et al
    An epidemic of bladder cancer: ten cases of bladder cancer in male Japanese workers exposed to ortho-toluidine.
    J Occup Health. 2018 May 9. doi: 10.1539/joh.2017-0220.
    PubMed     Text format     Abstract available


    J Urol

  36. MAKELA VJ, Kotsar A, Tammela TL, Murtola TJ, et al
    Bladder cancer survival in men using 5-alpha-reductase inhibitors.
    J Urol. 2018 May 3. pii: S0022-5347(18)43085-6. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available


    Jpn J Clin Oncol

  37. OUZAID I, Xylinas E
    Prevention of IVR: a need for investigation.
    Jpn J Clin Oncol. 2018;48:295-296.
    PubMed     Text format     Abstract available

  38. YOROZUYA W, Nishiyama N, Shindo T, Kyoda Y, et al
    Bacillus Calmette-Guerin may have clinical benefit for glandular or squamous differentiation in non-muscle invasive bladder cancer patients: retrospective multicenter study.
    Jpn J Clin Oncol. 2018 May 4. pii: 4992852. doi: 10.1093.
    PubMed     Text format     Abstract available


    Kaohsiung J Med Sci

  39. WU CL, Ho JY, Hung SH, Yu DS, et al
    miR-429 expression in bladder cancer and its correlation with tumor behavior and clinical outcome.
    Kaohsiung J Med Sci. 2018;34:335-340.
    PubMed     Text format     Abstract available


    Med Sci Monit

  40. ZHANG Y, Fang L, Zang Y, Xu Z, et al
    Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer.
    Med Sci Monit. 2018;24:3024-3033.
    PubMed     Text format     Abstract available


    Methods Mol Biol

  41. YOSHIDA T, Okuyama H, Endo H, Inoue M, et al
    Spheroid Cultures of Primary Urothelial Cancer Cells: Cancer Tissue-Originated Spheroid (CTOS) Method.
    Methods Mol Biol. 2018;1655:145-153.
    PubMed     Text format     Abstract available

  42. FUESSEL S, Lohse-Fischer A, Vu Van D, Salomo K, et al
    Quantification of MicroRNAs in Urine-Derived Specimens.
    Methods Mol Biol. 2018;1655:201-226.
    PubMed     Text format     Abstract available

  43. WHONGSIRI P, Phoyen S, Boonla C
    Oxidative Stress in Urothelial Carcinogenesis: Measurements of Protein Carbonylation and Intracellular Production of Reactive Oxygen Species.
    Methods Mol Biol. 2018;1655:109-117.
    PubMed     Text format     Abstract available

  44. MBANEFO EC, Hsieh MH
    Defining the Pathways of Urogenital Schistosomiasis-Associated Urothelial Carcinogenesis through Transgenic and Bladder Wall Egg Injection Models.
    Methods Mol Biol. 2018;1655:67-76.
    PubMed     Text format     Abstract available

  45. SJODAHL G
    Molecular Subtype Profiling of Urothelial Carcinoma Using a Subtype-Specific Immunohistochemistry Panel.
    Methods Mol Biol. 2018;1655:53-64.
    PubMed     Text format     Abstract available

  46. JAGUVA VASUDEVAN AA, Goering W, Haussinger D, Munk C, et al
    Detection of APOBEC3 Proteins and Catalytic Activity in Urothelial Carcinoma.
    Methods Mol Biol. 2018;1655:97-107.
    PubMed     Text format     Abstract available

  47. ALAMYAR M, Zwarthoff EC
    Analysis of Point Mutations in Clinical Samples of Urothelial Carcinoma.
    Methods Mol Biol. 2018;1655:19-28.
    PubMed     Text format     Abstract available


    Mol Clin Oncol

  48. OTSUKA M, Taguchi S, Nakagawa T, Morikawa T, et al
    Clinical significance of random bladder biopsy in primary T1 bladder cancer.
    Mol Clin Oncol. 2018;8:665-670.
    PubMed     Text format     Abstract available

  49. AKITAKE M, Kiyoshima K, Yokomizo A, Shiga K, et al
    A rational risk assessment for intravesical recurrence in primary low-grade Ta bladder cancer: A retrospective analysis of 245 cases.
    Mol Clin Oncol. 2018;8:785-790.
    PubMed     Text format     Abstract available


    Mol Med Rep

  50. LI C, Wang Z, Feng N, Dong J, et al
    Human HLAF adjacent transcript 10 promotes the formation of cancer initiating cells and cisplatin resistance in bladder cancer.
    Mol Med Rep. 2018 May 9. doi: 10.3892/mmr.2018.9005.
    PubMed     Text format     Abstract available

  51. PAN P, Chen T, Zhang Y, Qi Z, et al
    LIN28A inhibits lysosomeassociated membrane glycoprotein 1 protein expression in embryonic stem and bladder cancer cells.
    Mol Med Rep. 2018 May 3. doi: 10.3892/mmr.2018.8965.
    PubMed     Text format     Abstract available


    Oncol Lett

  52. YANG Y, Xu J, Zhang Q
    Detection of urinary survivin using a magnetic particles-based chemiluminescence immunoassay for the preliminary diagnosis of bladder cancer and renal cell carcinoma combined with LAPTM4B.
    Oncol Lett. 2018;15:7923-7933.
    PubMed     Text format     Abstract available

  53. CHEN JF, Yu BX, Ma L, Lv XY, et al
    RON is overexpressed in bladder cancer and contributes to tumorigenic phenotypes in 5637 cells.
    Oncol Lett. 2018;15:6547-6554.
    PubMed     Text format     Abstract available

  54. GAI JW, Wahafu W, Song L, Ping H, et al
    Expression of CD74 in bladder cancer and its suppression in association with cancer proliferation, invasion and angiogenesis in HT-1376 cells.
    Oncol Lett. 2018;15:7631-7638.
    PubMed     Text format     Abstract available

  55. ZHENG Z, Zhu D, Zhao F, Han J, et al
    Upregulated GAPLINC predicts a poor prognosis in bladder cancer patients and promotes tumor proliferation and invasion.
    Oncol Lett. 2018;15:6770-6776.
    PubMed     Text format     Abstract available

  56. CHEN D, Chen J, Guo Y, Li Y, et al
    Cinobufacini promotes apoptosis of bladder cancer cells by influencing the expression of autophagy-related genes.
    Oncol Lett. 2018;15:7104-7110.
    PubMed     Text format     Abstract available


    Oncol Rep

  57. LI WL, Yu HY, Zhang XJ, Ke M, et al
    Purple sweet potato anthocyanin exerts antitumor effect in bladder cancer.
    Oncol Rep. 2018 May 8. doi: 10.3892/or.2018.6421.
    PubMed     Text format     Abstract available


    Oncotarget

  58. HORI S, Miyake M, Tatsumi Y, Morizawa Y, et al
    Gamma-Klotho exhibits multiple roles in tumor growth of human bladder cancer.
    Oncotarget. 2018;9:19508-19524.
    PubMed     Text format     Abstract available


    Transl Androl Urol

  59. DIMITROPOULOS K, Tzortzis V
    Could there be a relationship between type of anesthesia and oncological parameters after transurethral resection of bladder cancer?
    Transl Androl Urol. 2018;7:287-288.
    PubMed     Text format    

  60. DREJER D, Jensen JB, Bryan RT
    Red patches during bladder cancer surveillance: to biopsy or not to biopsy?
    Transl Androl Urol. 2018;7:280-282.
    PubMed     Text format    

  61. CHRISTOPH F, Schostak M
    Age does not matter: the relevance of immediate instillation therapy with Mitomycin C in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2018;7:289-291.
    PubMed     Text format    

  62. KWEON TD, Lee KY
    Spinal anesthesia is associated with lower recurrence rates after resection of non-muscle invasive bladder cancer.
    Transl Androl Urol. 2018;7:283-286.
    PubMed     Text format    


    Urol Oncol

  63. SATHIANATHEN NJ, Fan Y, Jarosek SL, Lawrentschuk NL, et al
    Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study.
    Urol Oncol. 2018 May 3. pii: S1078-1439(18)30116.
    PubMed     Text format     Abstract available


    Urologe A

  64. ZAAK D, Ohlmann C, Stenzl A
    [Current and established diagnostic modalities for bladder cancer].
    Urologe A. 2018 May 9. pii: 10.1007/s00120-018-0650.
    PubMed     Text format     Abstract available


    World J Urol

  65. LENFANT L, Verhoest G, Campi R, Parra J, et al
    Perioperative outcomes and complications of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy for bladder cancer: a real-life, multi-institutional french study.
    World J Urol. 2018 May 9. pii: 10.1007/s00345-018-2313.
    PubMed     Text format     Abstract available


    Zhonghua Zhong Liu Za Zhi

  66. DING XL, Yang DL, Yan RP, Li ZP, et al
    [Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].
    Zhonghua Zhong Liu Za Zhi. 2018;40:308-312.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: